Portal hypertension as immune mediate disease. - Wikidata - wikimedia - TriplyDB

Portal hypertension as immune mediate disease.

Portal hypertension as immune mediate disease.

http://www.wikidata.org/entity/Q35197361

about

Oxidative stress in obesity: a critical component in human diseases The role of inhalational anesthetic drugs in patients with hepatic dysfunction: a review article.Role of the diet as a link between oxidative stress and liver diseases

P2860

Q28082703-561863D7-EE35-4383-939F-B13D0595DAE1 Q35148972-E0DA7203-4332-414C-BB94-55A47CF08080 Q38320278-4D177512-BF6C-4558-9C14-87710E980924

P2860

Portal hypertension as immune mediate disease.

http://www.wikidata.org/entity/Q35197361

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Portal hypertension as immune mediate disease.

@ast

Portal hypertension as immune mediate disease.

@en

type

label

Portal hypertension as immune mediate disease.

@ast

Portal hypertension as immune mediate disease.

@en

prefLabel

Portal hypertension as immune mediate disease.

@ast

Portal hypertension as immune mediate disease.

@en

P1433

Q35197361-48BDD3E5-51FA-459F-B662-14BB9E3967AE

P1476

Q35197361-8B962CD5-0DEE-48A9-875C-AD4DCFFEEDC1

P2093

Q35197361-2E307D49-A221-405C-8F50-F0A2C400167B

Q35197361-49B30A0A-E33A-402C-B2EF-391A1B549D60

Q35197361-57119FA2-B591-46EC-918F-9CF3C61EFB37

Q35197361-62CF8623-6809-4A19-88A7-6CFDE62E31DE

Q35197361-A858BB01-B29F-472E-A827-6A2B858B697D

Q35197361-C948D519-2887-45CA-8938-401159EDCCF0

Q35197361-F289E338-D966-4CDF-83DE-B0FEE6211B94

P2860

Q35197361-002FCA7F-8FA2-47ED-8D92-DE2179B6C832

Q35197361-07D59ABA-473B-42B9-A962-02A6111DAF57

Q35197361-09CE8E70-5ACC-4697-818F-3FE08E8491A4

Q35197361-1005FA46-800F-4C39-9F89-112F2274A480

Q35197361-14BAD057-EC6D-40EA-9417-6368ECC3DD8B

Q35197361-1F948D4A-5997-4C9E-AB01-7DF266A56C68

Q35197361-2394C615-3668-4C5F-99AE-7F9FDC63D16A

Q35197361-28ABB4DC-60A7-4C59-955F-55497348961F

Q35197361-2B5F7554-9EF3-4E10-ACD5-B50C5898DCEB

Q35197361-2D9B637B-047C-47F3-8837-B70D68C5C576

P304

Q35197361-3F9E7B21-BBDD-4269-8630-20F8E8ACE774

P31

Q35197361-975923B5-26C1-4BCD-9F8A-79B7D1390D0D

P356

Q35197361-6BF208A5-64CB-48A0-AD30-314A1BF6D8B1

P407

Q35197361-F13A4BED-F297-4178-94BB-4C84332B8808

P433

Q35197361-2EB88442-684F-4915-AB6D-516888B43556

P478

Q35197361-56A08CC5-D104-4BDF-86BD-093F1D7068C7

P50

Q35197361-9A5CBF62-6B7C-45F4-B16B-66C8513BAEBC

Q35197361-C16B155E-666C-41C2-88B5-764FA8C25750

P577

Q35197361-1C24406E-3213-4A78-817A-BE7AAF15B120

P5875

Q35197361-5D0BDCD4-654C-487B-BA1F-C991149C96BA

P698

Q35197361-023019DF-C925-45A2-91C2-B2B5628BED1A

P932

Q35197361-7C6C7744-9BAE-43C7-AD16-A7AC7ECEE2A8

P356

P1433

Hepatitis Monthly

P1476

Portal hypertension as immune mediate disease

@en

P2093

Carmelo Salpietro

http://www.w3.org/2001/XMLSchema#string

Caterina Cuppari

http://www.w3.org/2001/XMLSchema#string

Gabriella D'Angelo

http://www.w3.org/2001/XMLSchema#string

Lucia Marseglia

http://www.w3.org/2001/XMLSchema#string

Martina Filippelli

http://www.w3.org/2001/XMLSchema#string

Sara Manti

http://www.w3.org/2001/XMLSchema#string

Teresa Arrigo

http://www.w3.org/2001/XMLSchema#string

P2860

Splanchnic-aortic inflammatory axis in experimental portal hypertension

Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension

Novel role of nuclear receptor Rev-erbα in hepatic stellate cell activation: potential therapeutic target for liver injury

Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice

Management of portal hypertension-related bleeding.

Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients

Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.

Etiology of Portal Hypertension in Children:A Single Center's Experiences.

Autocrine VEGF signaling is required for vascular homeostasis.

Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.

P304

e18625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5812/HEPATMON.18625

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263517750

http://www.w3.org/2001/XMLSchema#string

P698

24976841

http://www.w3.org/2001/XMLSchema#string

P932

4071352

http://www.w3.org/2001/XMLSchema#string